Health In Tech reported third‑quarter 2025 revenue of $8.5 million, a 90% year‑over‑year increase from $4.46 million in Q3 2024. Nine‑month revenue reached $25.8 million, 132% of the full‑year 2024 total of $19.5 million. The jump is largely driven by a broader broker network and the recent launch of large‑employer underwriting on the eDIYBS platform, which now allows brokers to generate quotes for groups of 150 or more employees in as little as two weeks, compared with the industry’s typical three‑month timeline.
The company’s earnings per share were $0.01, exactly matching the consensus estimate of $0.01. The lack of a surprise is attributable to disciplined cost management: operating expenses fell to 55% of revenue from 68% in the prior year, while gross margin improved to 70.96% and net margin rose to 5.1%. These figures reflect a higher mix of high‑margin platform contracts and improved operational leverage as the business scales.
Health In Tech also highlighted two strategic milestones. On September 22, the company launched large‑employer underwriting within its eDIYBS platform, expanding its total addressable market into mid‑to‑large employers and positioning the firm to capture a segment that historically experiences longer processing times. On September 30, a non‑binding letter of intent was signed with AlphaTON Capital to explore a blockchain‑enabled claims platform aimed at reducing processing times and increasing transparency in the claims cycle, addressing an estimated $300 billion‑plus inefficiency in U.S. healthcare claims.
Management emphasized the significance of these developments. CEO Tim Johnson noted that the distribution ecosystem is “accelerating in strength” and that the new underwriting capability “extends the speed and scalability of our small‑business underwriting into the mid‑and large‑employer market.” CFO Julia Qian highlighted that profit increased 48% year‑over‑year, underscoring disciplined execution and a focus on strategic investments that reinforce the company’s leadership position and support sustainable long‑term performance.
Investors responded positively to the earnings, citing the strong revenue growth, operational efficiency, and the strategic initiatives that broaden the company’s market reach and technological capabilities.
revised_sentiment_rating
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.